A Pan-Cancer Analysis of SMARCA4 Alterations in Human Cancers

Ling Peng1, Jisheng Li2, Jie Wu3

  • 1Department of Respiratory Disease, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.

Frontiers in Immunology
|October 22, 2021
PubMed
Abstract

Insights

SMARCA4, a key component of the SWI/SNF complex, is highly expressed in many cancers and linked to poorer survival and altered tumor immunity. Its dysregulation impacts cancer progression and immune cell infiltration.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genomics

Background:

  • SMARCA4 is an essential ATPase subunit of the SWI/SNF chromatin remodeling complex.
  • This complex regulates gene transcription by altering chromatin structure.
  • SMARCA4 is increasingly recognized for its significant roles in human cancers.

Purpose of the Study:

  • To explore the potential role of SMARCA4 in various cancer types.
  • To provide insights into the pathologic mechanisms involving SMARCA4 in cancer.
  • To analyze the relationship between SMARCA4 and tumor immunity.

Main Methods:

  • Utilized The Cancer Genome Atlas (TCGA), GTEx, TIMER, and GSEA datasets.
  • Analyzed SMARCA4 expression, mutation, and phosphorylation status.
  • Investigated correlations with survival, pathological stage, DNA methylation, TMB, MSI, MMR, TME, and immune cell infiltration.

Main Results:

  • High SMARCA4 expression observed in most cancers, correlating with poor overall survival.
  • Altered SMARCA4 in lung adenocarcinoma indicated a poorer prognosis.
  • SMARCA4 dysregulation correlated with TMB, MSI, MMR, and DNA methylation, and showed associations with tumor immunity and immune cell infiltration, including negative association with CD8+ T-cell infiltration.

Conclusions:

  • Provided a comprehensive understanding of SMARCA4's oncogenic roles across diverse tumors.
  • Demonstrated a potential correlation between SMARCA4 and tumor immunity.
  • Suggested the involvement of SWI/SNF and ATPase complexes in SMARCA4's functional mechanisms, requiring further validation.

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.4K